Trial Profile
Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Glioma
- Focus Adverse reactions
- 02 Nov 2015 New trial record